75.48 0.00 (0.00%)
Pre-Market: 8:00AM EST
Previous Close | 80.63 |
Open | 80.61 |
Bid | 75.03 x 900 |
Ask | 77.50 x 1100 |
Day's Range | 75.17 - 80.97 |
52 Week Range | 19.51 - 92.60 |
Volume | 843,099 |
Avg. Volume | 882,005 |
Market Cap | 7.834B |
Beta (5Y Monthly) | 1.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.00 |
Earnings Date | May 05, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 92.42 |
Arrowhead submitted an IND to the U.S. Food and Drug Administration for ARO-APOC3, an RNAi therapeutic for hypertriglyceridemia
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Health Care Fund returned 17.1% (institutional shares). In comparison, the benchmark S&P 500 Index was up 12.15%, while the Russell 3000 Health Care Index was up 10.08%. You should […]
A look at the shareholders of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that used to be publicly owned tend to have lower insider ownership.